Student and Faculty Publications
Publication Date
11-10-2023
Journal
Med
Abstract
Frontline treatment and resultant cure rates in patients with advanced ovarian cancer have changed little over the past several decades. Here, we outline a multidisciplinary approach aimed at gaining novel therapeutic insights by focusing on the poorly understood minimal residual disease phase of ovarian cancer that leads to eventual incurable recurrences.
Keywords
Humans, Female, Neoplasm, Residual, Ovarian Neoplasms, Carcinoma, Ovarian Epithelial
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Medical Sciences Commons, Obstetrics and Gynecology Commons, Oncology Commons, Women's Health Commons
Comments
Supplementary Materials
PMID: 37951209